Hyderabad's startup Monitra Health raises $1.5M for domestic expansion, international certification

Hyderabad-based healthtech startup Monitra Health recently announced the closure of its pre-Series A funding round after raising $1.5 million led by Equanimity Ventures and Kotak Alternate Asset Managers. 

With this round of funding, The startup will focus on domestic expansion, international certifications, and product development for monitoring various biophysiological signals.

Monitra Health's flagship product upBeat

Monitra Health has developed a flagship product, upBeat, which it claims to be India's first full-stack remote cardiac monitoring platform designed for large-scale application.

The startup said its product has gained recognition for its precision in diagnosing conditions like unexplained fainting, dizziness, and palpitations. It is used by healthcare professionals, including cardiac electrophysiologists, cardiologists, neurologists, and MD physicians.

Research, patents, and certifications

The company's commitment to innovation is evident in its research efforts, with three pre-clinical studies and one clinical study, the results of which were presented at the European Heart Rhythm Association in April 2022.

Monitra Health holds patents in India and Australia and is awaiting patent approvals in the US, the EU, and Canada. It has also achieved significant certifications like ISO-13485 and CDSCO and is working towards CE and 510(k) FDA certifications for broader market access.

Expansion strategy 

Monitra Health operates on a B2B2C model, collaborating with healthcare professionals and medical device channel partners. The startup claims to have established a distribution network in Hyderabad, Kerala, and Maharashtra and plans to expand across India.

Additionally, It aims to venture into international markets, including SE Asia, Africa, Europe, and North America, after acquiring CE and FDA certifications.

Focusing on diversification 

Over the next five years, Monitra Health plans to diversify its platform to include monitoring for stroke, high-risk pregnancy, diabetes, newborn care, and more. 

Ravi Bhogu, CEO and Founder of Monitra Health, said, "This milestone propels our global mission to redefine continuous cardiac monitoring with upBeat®, our cutting-edge flagship product known for its accuracy and world-class reporting. This investment is pivotal for our growth, driving domestic expansion, international certifications, and innovation in monitoring various bio-physiological signals. Together, we aim to shape the future of healthcare at Monitra Health."

Join our new WhatsApp Channel for the latest startup news updates